Abiopharma

🔍 Anschell Jonathan (Executive)

Company: MATTEL INC /DE/ (MAT)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 51,909 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 51,909.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: The Restricted Stock Units ("RSUs" or "Units") were granted on May 1, 2026 pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended (the "Plan"). Each Unit represents a contingent right to receive one share of Mattel, Inc. Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of such share).
• F2: The RSUs vest as to (a) 33% of the Units granted on the first anniversary of the date of grant, (b) an additional 33% of the Units granted on the second anniversary of the date of grant, and (c) the remaining 34% of the Units granted on the third anniversary of the date of grant. On each vesting date, for each Unit vesting on such date, the Reporting Person will receive one share of Mattel, Inc. Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the date of vesting), subject to tax withholding.